PF-06687859(RG3039) CAS:1005504-62-0
PF-06687859(RG3039) 
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-1996 | 100mg | 425.00 | + Add to cart  | 
																					|
| R-C-1996 | 200mg | 790.00 | + Add to cart  | 
																					|
| R-C-1996 | 500mg | 1450.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							RG3039(PF-06687859)is a potent DcpS inhibitor.DcpS is a therapeutic target for spinal muscular atrophy.Spinal muscular atrophy(SMA)is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN.RG3039 improves motor function in SMA mice.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---PF-06687859(RG3039)  
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

